JD

Jeani Delagardelle

Independent Consultant

Burlingame, California

Overview 

Jeani Delagardelle is an accomplished Public & Private Board Director and Independent Consultant in Healthcare Technology, with a notable career spanning roles such as Managing Director/CoFounder at New Leaf Venture Partners and General Partner at Sprout Group. She has a strong background in Venture Capital, Mergers & Acquisitions, and IPOs, and has made significant investments in companies like ReShape Lifesciences and CardioKinetix. Currently based in Burlingame, California, Jeani's career highlights include serving as a Board Director at Worldheart (WHRT) and holding executive positions at prominent companies like Boston Scientific and Roche Pharmaceuticals.

Work Experience 

  • Public & Private Board Director/Independent-Healthcare Technology

    2018 - Current

    Over the past 21 years I have served as a Director on 24 Boards including both public and private companies, spanning multiple therapeutic areas and stages of companies from start ups to commercial stage. I have been on multiple Compensation Committees, Audit Committees, Financing Committees, Recruiting Committees and Chaired both Compensation and Audit Committees. I enjoy working closely with management teams and being an active Board Director.

  • Venture Partner/Board Director

    2018 - 2018

    Experienced venture investor and business leader who specializes in founding, building, growth expansion of healthcare technology companies across all stages of development and therapeutic areas for either acquisition or IPO.

  • Managing Director/CoFounder

    2005 - 2018

    Led our Medical Device investing practice.

New Leaf Venture Partners is a venture capital firm focused on investments in healthcare technology companies.

  • Public Company Board Director;Chair of the Compensation Committee

    2008 - 2012

    The Company developed an implantable ventricular assist device for adults, children and infants suffering from heart failure in the United States. The VAD's are mechanical assist devices that supplement the circulatory function of the heart by re-routing blood flow through a mechanical pump allowing for the restoration of normal blood flow. The Company was sold to Heartware, Inc. in 2012.

  • General Partner

    2000 - 2005

    Led the medical device investment practice.

  • General Partner

    1997 - 2000

    Led the medical device investment practice.

  • Vice President Global Marketing

    1996 - 1997

  • Business Unit Director

    1995 - 1996

    P & L Leadership for a Business Unit generating $63 million in sales. Special Achievement Award recipient in 1995.

  • Director of Product Marketing

    1994 - 1995

  • Group Product Marketing Manager

    1986 - 1994

    previous positions while at BSC include sales representative, Regional Manager.

Boston Scientific Scimed is develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Articles About Jeani

Relevant Websites